You Heard It Here First

more+
less-

Yesterday's Wall Street Journal has an interesting article about the FDA's off-label promotion ban being "in some jeopardy" after the Supreme Court's Sorrell decision, and pointing to the Caronia case, to be decided "within weeks," as the leading example of possible First Amendment scrutiny. Well, you heard it here first. We pointed out this implication of Sorrell back in June, the day that the Supreme Court decided the case. We've been following Caronia even longer. Glad to see the mainstream media waking up, that the government ability to monetize (to the tune of over $8 billion, according to the article) its First Amendment violations may be drawing to a long-overdue close.

Please see article below.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Administrative Agency Updates, Communications & Media Updates, Constitutional Law Updates, Products Liability Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Dechert LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »